Hijacking Host Immunity by the Human T-Cell Leukemia Virus Type-1: Implications for Therapeutic and Preventive Vaccines

CA Pise-Masison, G Franchini - Viruses, 2022 - mdpi.com
Human T-cell Leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma
(ATLL), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and other …

The past, present, and future of a human T-cell leukemia virus type 1 vaccine

JJ Tu, V Maksimova, L Ratner, AR Panfil - Frontiers in Microbiology, 2022 - frontiersin.org
Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus which
causes a lifelong infection. An estimated 5–10 million persons are infected with HTLV-1 …

Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis

S Olière, R Douville, A Sze, SM Belgnaoui… - Cytokine & growth factor …, 2011 - Elsevier
Infection with the Human T-cell Leukemia virus type I (HTLV-1) retrovirus results in a number
of diverse pathologies, including the aggressive, fatal T-cell malignancy adult T-cell …

Current perspectives in human T-cell leukemia virus type 1 infection and its associated diseases

M Miura, T Naito, M Saito - Frontiers in Medicine, 2022 - frontiersin.org
Human T-cell leukemia virus type 1 (HTLV-1) is a replication-competent human retrovirus
associated with two distinct types of diseases: a malignancy of mature CD4+ T cells called …

[HTML][HTML] HTLV-1 vaccination Landscape: Current developments and challenges

A Letafati, M Bahari, OS Ardekani, NN Jazi, A Nikzad… - Vaccine: X, 2024 - Elsevier
Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that is distinguished for its
correlation to myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T-cell …

HTLV-1 infection and its associated diseases

M Saito, P Jain, K Tsukasaki… - Leukemia research and …, 2012 - ncbi.nlm.nih.gov
It has been three decades since the discovery of human T-cell leukemia virus type 1 (HTLV-
1), which is the first human retrovirus etiologically associated with an aggressive malignancy …

Double control systems for human T‐cell leukemia virus type 1 by innate and acquired immunity

M Kannagi, A Hasegawa, S Kinpara, Y Shimizu… - Cancer …, 2011 - Wiley Online Library
Human T‐cell leukemia virus type 1 (HTLV‐1) is the causative retrovirus of adult T‐cell
leukemia (ATL) and HTLV‐1‐associated myelopathy/tropical spastic paraparesis …

How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy

A Pasquier, S Alais, L Roux, MI Thoulouze… - Frontiers in …, 2018 - frontiersin.org
Five to ten million individuals are infected by Human T-cell Leukemia Virus type 1 (HTLV-1).
HTLV-1 is transmitted through prolonged breast-feeding, by sexual contacts and by …

Establishment of a cynomolgus macaque model of human T-cell leukemia virus type 1 (HTLV-1) infection by direct inoculation of adult T-cell leukemia patient-derived …

E Urano, K Ueda, M Higuchi, M Furukawa… - Journal of …, 2022 - Am Soc Microbiol
HTLV-1 was discovered in the 1980s as the causative agent of adult T-cell leukemia and
HTLV-1-associated myelopathy/tropical spastic paraparesis. However, the precise …

New insights into the pathogenesis, diagnosis and treatment of human T-cell leukemia virus type 1-induced disease

D Pandya, S Rahman, B Wigdahl, ZK Khan, P Jain - 2007 - Taylor & Francis
It has been over 25 years since the discovery of human T-cell leukemia virus type 1 (HTLV-
1); however, the exact sequence of events that occur during primary infection, clinical …